Morgan Stanley »

Carmell Therapeutics Corp - US shares owned by Morgan Stanley

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8k 2.1k 1.33
2024-03-31 $5.3k 2.1k 2.56
2023-12-31 $7.9k 2.1k 3.81
2023-09-30 $7.5k 2.1k 3.60

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Tower Research Capital
Morgan Stanley
Bank of America Corporation

View all funds holding Carmell Therapeutics Corp - US